If your child has a brain or spine disorder, then we are here to help. Our focus is to partner with you, your child, and your family and bring the best care possible.
Our multidisciplinary team approach brings together more than 270 pediatric specialists, including board-certified pediatric neurologists and neurosurgeons, epileptologists, neonatologists, physiatrists, neuropsychologists and more. Because when it comes to brain and spine disorders, we know that it takes a team.
Intermountain Primary Children's Hospital is ranked by U.S. News & World Report as one of the nation's best children's hospitals in 11 of 11 pediatric specialties, including neurology and neurosurgery.
The Brain and Spine program is ranked #10 in the country for 2024-2025, and is ranked the #1 program for clinical outcomes.
All our providers are board certified/eligible and fellowship trained in pediatric specialties. Every year, they treat over 11,000 unique patients. They also perform over 500 neurosurgeries and 300 spine surgeries, and complete and analyze over 3,300 EEGs.
Our program is nationally ranked in the top 10 for Neurology and Neurosurgery by U.S. News & World Report. We are accredited as a Level IV Epilepsy Center (highest level). Our inpatient rehabilitation program uses Universal Data System for Medical Rehabilitation (UDSMR) and is accredited by Commission on Accreditation for Rehabilitation Facilities (CARF).
Neurological conditions can be very complex, so it’s critical to have a sub-specialty care team that includes nurse practitioners, nurse coordinators, counselors, geneticists, social workers, nutritionists, physical therapists, and pharmacists who understand the complexities of these conditions. We work together with specialists from multiple departments to ensure that each child receives the best possible care.
We are committed to providing the most innovative care using state-of-the-art technology and the latest research. Our team founded the Children’s Spine Study Group and co-founded the Hydrocephalus Clinical Research Network. We currently run more than 185 IRB approved clinical studies, including a gene therapy trial for Spinal Muscular Atrophy (SMA).
We offer full spectrum evaluations, including neuro-diagnostics, inpatient and outpatient assessments.